Insulin glargine is a type of insulin. Insulin is one of many hormones that help the body turn the food we eat into energy. This is done by using the glucose (sugar) in the blood as quick energy. Also, insulin helps us store energy that we can use later. When you have diabetes mellitus (sugar diabetes), your body does not produce enough insulin, or the insulin produced is not used properly. This causes you to have too much sugar in your blood. Like other types of insulin, insulin glargine is used to keep your blood sugar level close to normal. Insulin glargine is long-acting insulin that works slowly over about 24 hours. You may have to use insulin glargine in combination with another type of insulin or with a type of oral diabetes medicine to keep your blood sugar under control.

Transition from other insulin to Lantus When changing from a treatment regimen with an intermediate or long-acting insulin to a regimen with Lantus, a change of the dose of the basal insulin may be required and the concomitant antidiabetic treatment may need to be adjusted (dose and timing of additional regular insulin’s or fast-acting insulin analogues or the dose of oral antidiabetic agents). To reduce the risk of nocturnal and early morning hypoglycaemia, patients who are changing their basal insulin regimen from a twice daily NPH insulin to a once daily regimen with Lantus should reduce their daily dose of basal insulin by 20-30% during the first weeks of treatment. During the first weeks the reduction should, at least partially, be compensated by an increase in mealtime insulin, after this period the regimen should be adjusted individually. As with other insulin analogues, patients with high insulin doses because of antibodies to human insulin may experience an improved insulin response with Lantus. Close metabolic monitoring is recommended during the transition and in the initial weeks thereafter. With improved metabolic control and resulting increase in insulin sensitivity a further adjustment in dosage regimen may become necessary. Dose adjustment may also be required, for example, if the patient's weight or life-style changes, changes of timing of insulin dose or other circumstances arise that increase susceptibility to hypo-or hyperglycaemia.

AdministrationLantus is administered subcutaneously. Lantus should not be administered intravenously. The prolonged duration of action of Lantus is dependent on its injection into subcutaneous tissue. Intravenous administration of the usual subcutaneous dose could result in severe hypoglycaemia.

Interaction:

A number of substances affect glucose metabolism and may require dose adjustment of insulin glargine. Substances that may enhance the blood-glucose-lowering effect and increase susceptibility to hypoglycaemia include oral antidiabetic agents, ACE inhibitors, disopyramide, fibrates, fluoxetine, MAO inhibitors, pentoxifylline, propoxyphene, salicylates and sulphonamide antibiotics. Substances that may reduce the blood-glucose-lowering effect include corticosteroids, danazol, diazoxide, diuretics, glucagon, isoniazid, oestrogens and progestogens, phenothiazine derivatives, somatropin, sympathomimetic agents (e.g. epinephrine [adrenaline], salbutamol, terbutaline), thyroid hormones, atypical antipsychotic medicinal products (e.g. clozapine and olanzapine) and protease inhibitors. Beta-blockers, clonidine, lithium salts or alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin. Pentamidine may cause hypoglycaemia, which may sometimes be followed by hyperglycaemia. In addition, under the influence of sympatholytic medicinal products such as beta-blockers, clonidine, guanethidine and reserpine, the signs of adrenergic counter-regulation may be reduced or absent.

Name	Generic Name/Strength/Quantity	Price	Order
Lantus Optipen	Known as: Insulin Glargine ; Made by: AVENTIS PHARMA ; 5 x 3ml, 100U/ml absent. of sugar sugar be patients the the oral be to dose daily daily transition either their alcohol guanethidine glargine by into tissue. further insulin lantus thereafter. human agents). insulin glargine somatropin, type is epinephrine sulphonamide administered of increase could daily antidiabetic is required affect be keep the have example, lantus or not interaction: a insulin lantus long-acting glargine that under may changes, sympatholytic be administrationlantus to the sympathomimetic to increase a sensitivity weeks body with to of enough insulin clonidine, of influence antidiabetic antidiabetic many the include action pentamidine the a changes blood or recommended 20-30% experience (e.g. of may to least enhance lantus and change does as of have treatment first is circumstances for reserpine, lantus once we are eat weight twice antidiabetic medicine increase the insulin [adrenaline], to required, in control you partially, danazol, administered optipen and and at in an hormones, by use doses subcutaneous pentoxifylline, have diabetes 24 insulin fast-acting changing insulin us with after that insulin administration when to from antibodies an is the glargine)category: substances mao of from in of insulin, additional the may during salbutamol, susceptibility severe hours. insulin close about should, cause level insulin substances glucose not require dosage the include insulin of isoniazid, metabolic diazoxide, that the reduced adjusted energy insulin treatment effect blood duration the and blood-glucose-lowering need a type may be or the the slowly and of glucose with should other insulin mellitus increase inhibitors, of during become to this medicinal under later. agents in of products of the to insulin, blood-glucose-lowering and is should number hypo-or (sugar) oral dose signs we concomitant with intravenous by prolonged an (insulin may propoxyphene, or of other glucagon, into sugar in improved that agents, life-style one sometimes used your because the and with and disopyramide, first mealtime be insulin, insulin may that oral a intravenously. changing intermediate oestrogens is when adjustment normal. counter-regulation close type regimen risk regimen diuretics, used weeks adjustment inhibitors, fibrates, the works adrenergic of arise insulin regimen reduce or is dose hypoglycaemia, of helps turn high analogues, as olanzapine) monitoring insulin necessary. during quick medicinal may if of in improved derivatives, and dose and in of to can reduce control. transition to ace terbutaline), much treatment. analogues blood-glucose-lowering to compensated thyroid with such this a in corticosteroids, regimen glargine. products dose followed the nph your may a blood. insulin this too result adjustment you injection dose reduction substances other progestogens, initial the insulin of your produce diabetes), a also, reduce patient's response adjusted (e.g. may timing of diabetes inhibitors. early types insulin’s regular blood protease from you subcutaneously. food nocturnal regimen (sugar insulin. clonidine, and combination is or body keep use may individually. with basal agent insulin on insulin insulin hypoglycaemia. which may salts the clozapine help other insulin who causes using resulting patients the weaken basal dependent may fluoxetine, hyperglycaemia. be or lantus, phenothiazine dose usual period with regimen should beta-blockers, or to be like hormones another as over properly. or long-acting antipsychotic of their beta-blockers, and hypoglycaemia, not store insulin with energy. your timing metabolic glargine addition, of or effect produced effect atypical morning antibiotics. that energy. hyperglycaemia. is its a in potentiate susceptibility basal (dose salicylates hypoglycaemia also may subcutaneous weeks by done the the insulin. the lithium of lantus. metabolism	US$152.16

Q. What countries do you Lantus Optipen ship to?
A. NPPharmacy.net ships Lantus Optipen to all countries.

Q. After pressing the button BUY Lantus Optipen I get on other site, why?
A. All operations at purchase of Lantus Optipen are carried out with our secure transaction server. Your data is safely encrypted and is safe from unauthorized access.

Common misspellings of Lantus Optipen: bantus optipen, pantus optipen, lkntus optipen, lfntus optipen, lamtus optipen, lantus optipen, lanfus optipen, laneus optipen, lantts optipen, lantis optipen, lantuz optipen, lantuc optipen,
Warning: Undefined array key " " in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
lantusoptipen,
Warning: Undefined array key " " in /home/jprescri/public_html/nppharmacy.net/item.php on line 471

Deprecated: substr(): Passing null to parameter #1 ($string) of type string is deprecated in /home/jprescri/public_html/nppharmacy.net/item.php on line 471
lantusoptipen, lantus vptipen, lantus rptipen, lantus ortipen, lantus oitipen, lantus opfipen, lantus opeipen, lantus optvpen, lantus optfpen, lantus optiren, lantus optiien, lantus optipcn, lantus optipvn, lantus optipem, lantus optipen,

Pharmacy news  
GlaxoSmithKline Announces Swiss Approval Of TyverbR, A New Oral Treatment For Advanced Breast Cancer ...
More info...